Literature DB >> 5422912

Diagnosis of neuroblastoma by qualitative and quantitative determination of catecholamine metabolites in urine.

S E Gitlow, L M Bertani, A Rausen, D Gribetz, S W Dziedzic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5422912     DOI： 10.1002/1097-0142(197006)25:6<1377::aid-cncr2820250616>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  6 in total

1.  Neuroblastoma mass screening in infancy in Kyoto, Japan.

Authors:  T Sawada; H Kawakatsu; T Sugimoto; Y Horii; K Kuroda; H Hosoi; T Saida; T Hino; T Michihata
Journal:  Indian J Pediatr       Date:  1987 Nov-Dec       Impact factor: 1.967

2.  Unusual presenting symptoms in neuroblastoma.

Authors:  J V Bond
Journal:  Br Med J       Date:  1972-05-06

3.  Clinical significance of catecholamine excretion levels in diagnosis and treatment of neuroblastoma.

Authors:  J V Bond
Journal:  Arch Dis Child       Date:  1975-09       Impact factor: 3.791

4.  Recent advances in neuroblastoma.

Authors:  J Z Finklestein; G S Gilchrist
Journal:  Calif Med       Date:  1972-03

5.  Clinicopathological role of tumour index substances in paediatric neoplasia.

Authors:  A M Neville; K Grigor; E Heyderman
Journal:  J Clin Pathol       Date:  1976-11       Impact factor: 3.411

6.  Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma.

Authors:  Giuliana Cangemi; Giorgio Reggiardo; Sebastiano Barco; Laura Barbagallo; Massimo Conte; Paolo D'Angelo; Maurizio Bianchi; Claudio Favre; Barbara Galleni; Giovanni Melioli; Riccardo Haupt; Alberto Garaventa; Maria V Corrias
Journal:  Onco Targets Ther       Date:  2012-11-30       Impact factor: 4.147
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.